Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Harada

Showing results (141-150 of 147) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 147 results.
Circulation Reports|February 12, 2024
Sex Differences in 5-Year Outcomes After Deferral of Revascularization Following Physiological Coronary AssessmentTakayuki Ishihara, Shoichi Kuramitsu, Hitoshi Matsuo, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Five-Year Outcomes After Fractional Flow Reserve-Guided Deferral of Revascularization in Infarct-Related Artery LesionsHirofumi Ohashi, Shoichi Kuramitsu, Hiroaki Takashima, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 14, 2022
Long-Term Outcomes in Elderly Patients After Deferral of Coronary Revascularization Guided by Fractional Flow ReserveYasushi Ueki, Shoichi Kuramitsu, Tatsuya Saigusa, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 2, 2022
Association of guideline-directed medical therapy adherence with outcomes after fractional flow reserve-based deferral of revascularizationMasanobu Ishii, Shoichi Kuramitsu, Kenshi Yamanaga, et al.
Circulation Reports|August 12, 2024
Impact of Antiplatelet Therapy on 5-Year Outcomes After Fractional Flow Reserve-Guided Deferral of Revascularization in Nonsignificant Obstructive Coronary Artery DiseaseTairo Kurita, Shoichi Kuramitsu, Masanobu Ishii, et al.
Journal of the American Heart Association|October 7, 2023
Prognostic Impact of Renal Function on 5-Year Outcomes After Fractional Flow Reserve-Guided Deferral of RevascularizationRyosuke Itakura, Shoichi Kuramitsu, Jun Kikuchi, et al.
Blood Advances|July 2, 2026
Real-World Outcomes with BCMA- and GPRC5D-Targeting Bispecific Antibodies in Plasma Cell LeukemiaMahmoud R Gaballa, Kelley Julian, Aimaz Afrough, et al.
Pageof 15

Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
Circulation Reports|February 12, 2024
Sex Differences in 5-Year Outcomes After Deferral of Revascularization Following Physiological Coronary AssessmentTakayuki Ishihara, Shoichi Kuramitsu, Hitoshi Matsuo, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Five-Year Outcomes After Fractional Flow Reserve-Guided Deferral of Revascularization in Infarct-Related Artery LesionsHirofumi Ohashi, Shoichi Kuramitsu, Hiroaki Takashima, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 14, 2022
Long-Term Outcomes in Elderly Patients After Deferral of Coronary Revascularization Guided by Fractional Flow ReserveYasushi Ueki, Shoichi Kuramitsu, Tatsuya Saigusa, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 2, 2022
Association of guideline-directed medical therapy adherence with outcomes after fractional flow reserve-based deferral of revascularizationMasanobu Ishii, Shoichi Kuramitsu, Kenshi Yamanaga, et al.
Circulation Reports|August 12, 2024
Impact of Antiplatelet Therapy on 5-Year Outcomes After Fractional Flow Reserve-Guided Deferral of Revascularization in Nonsignificant Obstructive Coronary Artery DiseaseTairo Kurita, Shoichi Kuramitsu, Masanobu Ishii, et al.
Journal of the American Heart Association|October 7, 2023
Prognostic Impact of Renal Function on 5-Year Outcomes After Fractional Flow Reserve-Guided Deferral of RevascularizationRyosuke Itakura, Shoichi Kuramitsu, Jun Kikuchi, et al.
Blood Advances|July 2, 2026
Real-World Outcomes with BCMA- and GPRC5D-Targeting Bispecific Antibodies in Plasma Cell LeukemiaMahmoud R Gaballa, Kelley Julian, Aimaz Afrough, et al.
Pageof 15